Stockreport

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, Sept. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and [Read more]